About the MBD Center (COBRE)
The Metabolic Basis of Disease Center (MBDC) was developed to support early-career scientists as they study the metabolic networks that become dysregulated during the progression of various diseases including diabetes, obesity, preeclampsia, and anxiety.
Led by Jacqueline Stephens, PhD, the Metabolic Basis of Disease Center will increase the number of scientists whose research addresses important health challenges while enabling these young investigators to establish independent research programs with sustainable independent funding.
Learn more about the 2020 launch of the Metabolic Basis of Disease Center here.
Aims
All research studies conducted within the Metabolic Basis of Disease Center:
- Enable the growth of young, knowledgeable faculty and expand our scientific infrastructure to promote biomedical research discoveries that will increase our understanding of the metabolic features of a variety of different diseases.
- Discover the triggers of chronic diseases through innovative research that improves human health across the lifespan.
- Focus on various aspects of metabolic diseases with the use of innovative methods.
Pilot and Feasibility Program
The COBRE Metabolic Basis of Disease Center (MBDC) functions to expand intellectual, scientific, and technical infrastructure to promote biomedical research that enhances the study of metabolic components of disease states.
Approximately $150,000/year is available to fund 2-4 Pilot and Feasibility (P&F) awards each year. The P&F program will support innovative research on the metabolic basis of disease, focusing on projects expected to be competitive for further extramural funding.
